86 results
DEFA14A
RYTM
Rhythm Pharmaceuticals Inc.
26 Apr 24
Additional proxy soliciting materials
4:10pm
materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials … on the reverse side on or before June 8, 2024 to facilitate timely delivery. 2NOT Easy Online Access — View your proxy materials and vote. When you go
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
controls, policies and procedures, including oversight, access controls, encryption, technological and physical safeguards and business continuity … /disaster recovery and security plans that are designed to protect against and prevent unauthorized access to or acquisition of Data used in connection
424B5
RYTM
Rhythm Pharmaceuticals Inc.
29 Feb 24
Prospectus supplement for primary offering
4:44pm
access for IMCIVREE for BBS or POMC and LEPR deficiencies, or both, in 14 countries, and we continue to collaborate with authorities to achieve access … access for IMCIVREE for BBS or POMC and LEPR deficiencies, or both, in seven markets in Europe and Argentina, and we continue to collaborate
8-K
3afuahw9
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
EX-3.1
8sb38
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
EX-99.1
1ov2 h2xs1rp26
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
akkeui24c
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
DEFA14A
7rqtynuz
27 Apr 23
Additional proxy soliciting materials
5:09pm
8-K
EX-99.1
c6x8edzaldmhsjospk
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am
8-K
EX-1.1
48l8yrez
15 Sep 22
Other Events
4:02pm
424B5
z2j3r4rluswl 9gf6
15 Sep 22
Prospectus supplement for primary offering
4:00pm
424B5
lyr 2o79c6sv43qluw
14 Sep 22
Prospectus supplement for primary offering
4:05pm